AGP Picks
View all

World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

Press releases published on October 1, 2026

Taiwan Excellence Builds Taiwan-U.S. Connections Through Innovation and Culture at Taiwan Expo USA 2026
Daxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
Aktis Oncology Initiates Second Phase 1b Clinical Trial for AKY-2519, a Miniprotein Radioconjugate Targeting B7-H3
Habit Is Giving Away Alex Vesia Bobbleheads. Yes, He’s Holding His Double Play Char
Artiva Biotherapeutics Highlights Updated AlloNK® Data in Sjögren Disease Presented at the 17th International Symposium on Sjögren’s Disease (ISSjD 2026)
Helus Pharma Announces Completion of Legal Name Change
Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD
Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development
Galimedix Therapeutics presents baseline data from Phase 2 eDREAM trial highlighting patient-tailored microperimetry as a sensitive and precise functional measurement in geographic atrophy studies
Edible Garden Purchases a 6.2 Acre Building in Webster City, Iowa to Develop 100+ Million Unit Ready-to-Drink Manufacturing Platform
Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting
OrthoPediatrics Sponsors the 10th Pediatric Orthopedic Surgical Techniques Course
Caspian Therapeutics Appoints Manasi Jaiman, M.D., M.P.H., and Elizabeth Mily to Board of Directors
MitoRx Therapeutics presents new preclinical data on MTRX31, demonstrating restored mitochondrial density, at the 62nd EASD Annual Meeting
What Are the 5 Signs of Poor Metabolic Health Adults May Overlook?
One of the most remote infrastructure projects in the US takes shape in Alaska
Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences
Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD Risk

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

World Wellness Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.